Healius will write to the Takeovers Panel to resolve “deficiencies” in the bold takeover bid made by its smaller rival, Australian Clinical Laboratories.

The escalation in hostilities comes a day after Healius’ largest shareholders, Perpetual and John Wylie’s Tanarra Capital, declined to support ACL’s audacious offer, in effect killing the deal on Sunday.